Herpes simian B Virus | |
---|---|
Virus classification | |
Group: | Group I (dsDNA) |
Family: | Herpesviridae |
Subfamily: | Alphaherpesvirinae |
Genus: | Simplexvirus |
Herpes simian B virus (Macacine herpesvirus 1 (formerly Cercopithecine herpesvirus 1, CHV-1), Herpesvirus simiae, B virus) is the endemic simplexvirus of macaque monkeys. B virus is an alphaherpesvirus, which consists of a subset of herpes viruses that travel within hosts using the peripheral nerves. As such, this neurotropic virus is not found in the blood.
In the natural host, the virus exhibits pathogenesis similar to that of herpes simplex virus (HSV) in humans. Conversely, when humans are zoonotically infected with B virus, patients can present with severe central nervous system disease, resulting in permanent neurological dysfunction or death. Severity of the disease increases for untreated patients, with a case fatality rate of approximately 80%. Early diagnosis and subsequent treatment are crucial to human survival of the infection.
Linked with more than two dozen deaths since its discovery, B virus is the only identified nonhuman primate herpesvirus that displays severe pathogenicity in humans. The last identified case of human B virus infection occurred in 2008, with the last known fatality occurring in 1997 when researcher Elizabeth Griffin was splashed in the eye at Yerkes National Primate Research Center. Proper personal protective equipment is essential when working with macaques, especially those animals that have tested positive for the virus. Bites, scratches and exposures to mucous membranes, including the eye, must be cleaned immediately.
Since the identification of the virus in 1932, there have been 31 documented cases of human B virus infection, 21 of which led to death. At least 20 of the patients developed some degree of encephalitis.